XML 65 R60.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidating Statement of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
May. 31, 2015
May. 31, 2014
May. 31, 2015
May. 31, 2014
Cash flows from operating activities:        
Net earnings (loss) $ 70,325 $ 46,096 $ 167,353 $ 89,646
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:        
Deferred income taxes     (5,245) (6,745)
Depreciation and amortization     33,258 30,824
Net (gain) loss on disposition of equipment (720) (5,619) (924) (14,686)
Stock based compensation expense     13,176 6,454
Noncontrolling interest adjustments     20,371 2,953
Other     1,008 388
Decrease (increase) in assets:        
Accounts receivable     (8,769) (26,226)
Inventories     (124,906) (21,722)
Leased railcars for syndication     (90,914) (25,420)
Other     (1,666) (2,491)
Increase (decrease) in liabilities:        
Accounts payable and accrued liabilities     23,135 36,507
Deferred revenue     3,680 12,258
Net cash provided by (used in) operating activities     29,557 81,740
Cash flows from investing activities:        
Proceeds from sales of assets     4,628 39,515
Capital expenditures     (75,892) (34,522)
Decrease (increase) in restricted cash     228 (661)
Investment in and net advances to unconsolidated affiliates     (29,923) (1,253)
Other     715  
Net cash provided by (used in) investing Activities     (100,244) 3,079
Cash flows from financing activities:        
Net changes in revolving notes with maturities of 90 days or less     73,000  
Proceeds from revolving notes with maturities longer than 90 days     42,563 34,674
Repayment of revolving notes with maturities longer than 90 days     (36,137) (64,801)
Repayments of notes payable     (5,504) (126,821)
Proceeds from notes payable       200,000
Debt issuance costs       (382)
Repurchase of stock     (48,451) (26,293)
Dividends     (12,069)  
Decrease in restricted cash     11,000  
Cash distribution to joint venture partner     (12,489) (3,109)
Investment by joint venture partner       419
Excess tax benefit from restricted stock awards     2,964 109
Other     (248)  
Net cash provided by (used in) financing activities     14,629 13,796
Effect of exchange rate changes     (6,075) 2,442
Increase (decrease) in cash and cash equivalents     (62,133) 101,057
Beginning of period     184,916 97,435
End of period 122,783 198,492 122,783 198,492
Parent        
Cash flows from operating activities:        
Net earnings (loss) 42,811 33,588 125,948 64,563
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:        
Deferred income taxes     (138) (4,194)
Depreciation and amortization     1,484 1,427
Stock based compensation expense     13,176 6,454
Other     43  
Decrease (increase) in assets:        
Accounts receivable     50 36,573
Other     20,641 (1,220)
Increase (decrease) in liabilities:        
Accounts payable and accrued liabilities     (3,824) (22,404)
Deferred revenue     (122) (116)
Net cash provided by (used in) operating activities     157,258 81,083
Cash flows from investing activities:        
Capital expenditures     (2,424) (3,543)
Investment in and net advances to unconsolidated affiliates     (245,594) (91,939)
Other     715  
Net cash provided by (used in) investing Activities     (247,303) (95,482)
Cash flows from financing activities:        
Net changes in revolving notes with maturities of 90 days or less     73,000  
Repayments of notes payable     (5)  
Intercompany advances     (18,997) 137,633
Repurchase of stock     (48,451) (26,293)
Dividends     (12,069)  
Excess tax benefit from restricted stock awards     2,964 109
Other     (248)  
Net cash provided by (used in) financing activities     (3,806) 111,449
Increase (decrease) in cash and cash equivalents     (93,851) 97,050
Beginning of period     149,747 63,173
End of period 55,896 160,223 55,896 160,223
Combined Guarantor Subsidiaries        
Cash flows from operating activities:        
Net earnings (loss) 39,625 37,001 138,166 72,006
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:        
Deferred income taxes     (8,000) (1,789)
Depreciation and amortization     19,909 20,713
Net (gain) loss on disposition of equipment (724) (5,411) (927) (13,556)
Other     105 372
Decrease (increase) in assets:        
Accounts receivable     (10,046) (43,867)
Inventories     (39,279) 20,456
Leased railcars for syndication     (109,324) (28,371)
Other     763 81
Increase (decrease) in liabilities:        
Accounts payable and accrued liabilities     25,612 9,143
Deferred revenue     4,078 10,798
Net cash provided by (used in) operating activities     21,057 45,986
Cash flows from investing activities:        
Proceeds from sales of assets     4,623 38,509
Capital expenditures     (18,807) (9,929)
Decrease (increase) in restricted cash     229 (660)
Investment in and net advances to unconsolidated affiliates     (19,966) (7,710)
Net cash provided by (used in) investing Activities     (33,921) 20,210
Cash flows from financing activities:        
Repayments of notes payable     (5,280) (126,400)
Intercompany advances     9,788 (139,741)
Proceeds from notes payable       200,000
Debt issuance costs       (382)
Decrease in restricted cash     11,000  
Net cash provided by (used in) financing activities     15,508 (66,523)
Effect of exchange rate changes     (2,269) 362
Increase (decrease) in cash and cash equivalents     375 35
Beginning of period     112 25
End of period 487 60 487 60
Combined Non-Guarantor Subsidiaries        
Cash flows from operating activities:        
Net earnings (loss) 56,873 28,746 146,501 58,111
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:        
Deferred income taxes     2,893 (762)
Depreciation and amortization     11,936 8,746
Net (gain) loss on disposition of equipment 7 (205) 7 (820)
Other     860 16
Decrease (increase) in assets:        
Accounts receivable     37,034 694
Inventories     (87,156) (42,225)
Other     (33,634) (2,788)
Increase (decrease) in liabilities:        
Accounts payable and accrued liabilities     9,112 31,774
Deferred revenue     (276) 1,574
Net cash provided by (used in) operating activities     87,277 54,320
Cash flows from investing activities:        
Proceeds from sales of assets     5 1,006
Capital expenditures     (55,059) (21,050)
Decrease (increase) in restricted cash     (1) (1)
Investment in and net advances to unconsolidated affiliates       (1,253)
Net cash provided by (used in) investing Activities     (55,055) (21,298)
Cash flows from financing activities:        
Proceeds from revolving notes with maturities longer than 90 days     42,563 34,674
Repayment of revolving notes with maturities longer than 90 days     (36,137) (64,801)
Repayments of notes payable     (219) (421)
Intercompany advances     9,209 2,108
Cash distribution to joint venture partner     (12,489) (3,109)
Investment by joint venture partner       419
Net cash provided by (used in) financing activities     2,927 (31,130)
Effect of exchange rate changes     (3,806) 2,080
Increase (decrease) in cash and cash equivalents     31,343 3,972
Beginning of period     35,057 34,237
End of period 66,400 38,209 66,400 38,209
Eliminations        
Cash flows from operating activities:        
Net earnings (loss) (68,984) (53,239) (243,262) (105,034)
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:        
Depreciation and amortization     (71) (62)
Net (gain) loss on disposition of equipment $ (3) $ (3) (4) (310)
Noncontrolling interest adjustments     20,371 2,953
Decrease (increase) in assets:        
Accounts receivable     (35,807) (19,626)
Inventories     1,529 47
Leased railcars for syndication     18,410 2,951
Other     10,564 1,436
Increase (decrease) in liabilities:        
Accounts payable and accrued liabilities     (7,765) 17,994
Deferred revenue       2
Net cash provided by (used in) operating activities     (236,035) (99,649)
Cash flows from investing activities:        
Capital expenditures     398  
Investment in and net advances to unconsolidated affiliates     235,637 99,649
Net cash provided by (used in) investing Activities     $ 236,035 $ 99,649